Esperion Therapeutics (NASDAQ:ESPR) reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Esperion Therapeutics missed estimated earnings by 12.9%, reporting an EPS of $-1.05 versus an estimate of $-0.93.

Revenue was down $21.82 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 2.3% drop in the share price the next day.

Here's a look at Esperion Therapeutics's past performance:

To track all earnings releases for Esperion Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.